Home LiteratureArticle Details
PMID: 8504962 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

p53 expression and K-ras mutation in colorectal adenomas.

Gut ·Vol. 34 ·No. 5 ·1993-05-00 ·Pages 621-4

Scott N, Bell SM, Sagar P, Blair GE, Dixon MF, Quirke P

Abstract

The frequency of p53 overexpression and K-ras codon 12 mutation was investigated in a series of colorectal adenomas. p53 was detected by immunohistochemistry in only 5% of tumours, whereas K-ras mutation was found in eight of 30 adenomas examined. In vitro, mutant p53 and ras genes cooperate to transform primary rat cells into a tumourigenic cell line. The presence of both p53 overexpression and K-ras mutation in a benign tubulovillous polyp in the present series suggests that in vivo this combination of events is insufficient to cause malignant transformation of a large bowel adenoma.

Related Genes
MeSH Terms
Adenoma/chemistry,genetics Colorectal Neoplasms/chemistry,genetics Genes, p53/genetics Genes, ras/genetics Humans Immunohistochemistry Intestinal Polyps/chemistry,genetics Mutation/genetics Tumor Suppressor Protein p53/analysis
Chemicals
Tumor Suppressor Protein p53
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Scott N
Academic Unit of Pathology, University of Leeds.
Bell S M
Sagar P
Blair G E
Dixon M F
Quirke P
References (28)
28 references, click to expand
  1. p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study.
    J Pathol. 1991 May;164(1):75-81 PMID: 2056391
  2. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers.
    Science. 1991 Mar 15;251(4999):1366-70 PMID: 1848370
  3. Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas.
    Cancer Res. 1991 Aug 15;51(16):4436-42 PMID: 1868464
  4. Identification of deletion mutations and three new genes at the familial polyposis locus.
    Cell. 1991 Aug 9;66(3):601-13 PMID: 1678319
  5. Occurrence of Ki-ras and p53 mutations in primary colorectal tumors.
    Oncogene. 1991 Nov;6(11):2121-8 PMID: 1945416
  6. P53 in tumour pathology: can we trust immunocytochemistry?
    J Pathol. 1992 Apr;166(4):329-30 PMID: 1517889
  7. Pathology of colorectal adenomas: a colonoscopic survey.
    J Clin Pathol. 1982 Aug;35(8):830-41 PMID: 7107955
  8. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells.
    Nature. 1984 Dec 13-19;312(5995):646-9 PMID: 6095116
  9. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.
    Nature. 1984 Dec 13-19;312(5995):649-51 PMID: 6390217
  10. Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53.
    Nature. 1984 Dec 13-19;312(5995):651-4 PMID: 6095117
  11. Hypomethylation of DNA from benign and malignant human colon neoplasms.
    Science. 1985 Apr 12;228(4696):187-90 PMID: 2579435
  12. The cellular protein p53 in human tumours.
    Mol Biol Med. 1984 Aug;2(4):261-72 PMID: 6544917
  13. Prevalence of ras gene mutations in human colorectal cancers.
    Nature. 1987 May 28-Jun 3;327(6120):293-7 PMID: 3587348
  14. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.
    Nature. 1987 May 28-Jun 3;327(6120):298-303 PMID: 2438556
  15. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene.
    Oncogene. 1988 May;2(5):445-52 PMID: 3287278
  16. Genetic alterations during colorectal-tumor development.
    N Engl J Med. 1988 Sep 1;319(9):525-32 PMID: 2841597
  17. Expression of the nuclear oncogene p53 in colon tumours.
    J Pathol. 1989 Mar;157(3):193-9 PMID: 2926561
  18. The p53 proto-oncogene can act as a suppressor of transformation.
    Cell. 1989 Jun 30;57(7):1083-93 PMID: 2525423
  19. Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer.
    Oncogene. 1989 Jul;4(7):923-8 PMID: 2666911
  20. Increased expression of mutant forms of p53 oncogene in primary lung cancer.
    Lancet. 1990 Mar 24;335(8691):675-9 PMID: 1969059
  21. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.
    EMBO J. 1990 May;9(5):1595-602 PMID: 1691710
  22. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.
    Oncogene. 1990 Jun;5(6):893-9 PMID: 1694291
  23. Suppression of human colorectal carcinoma cell growth by wild-type p53.
    Science. 1990 Aug 24;249(4971):912-5 PMID: 2144057
  24. p53 mutations in colorectal cancer.
    Proc Natl Acad Sci U S A. 1990 Oct;87(19):7555-9 PMID: 1699228
  25. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.
    Cancer Res. 1990 Dec 1;50(23):7717-22 PMID: 2253215
  26. Genetic mechanisms of tumor suppression by the human p53 gene.
    Science. 1990 Dec 14;250(4987):1576-80 PMID: 2274789
  27. p53 in colorectal cancer: clinicopathological correlation and prognostic significance.
    Br J Cancer. 1991 Feb;63(2):317-9 PMID: 1997114
  28. c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis.
    Br J Cancer. 1991 Jul;64(1):174-8 PMID: 1854618
Article Info
Journal
Gut
Abbr.
Gut
ISSN
0017-5749
Published
1993-05-00
Pages
621-4
Language
English
Region
England
NLM ID
2985108R
PMCID
PMC1374178
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]